Bausch Health Companies Inc. (NASDAQ:BHC) | Finanzwire

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Headlines Articles Press releases Bausch Health Companies Inc.

Home
Companies
Bausch Health Companies Inc.

BRIEF

published on 01/17/2025 at 15:30, 10 months 18 days ago

Bausch Health Acknowledges XIFAXAN's Selection for Medicare Negotiation

XIFAXAN Bausch Health Medicare Negotiation Drug Pricing Healthcare Policy
PRESS RELEASE

published on 01/17/2025 at 15:25, 10 months 18 days ago

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Bausch Health and Salix Pharmaceuticals announce XIFAXAN selected for drug price negotiation program with CMS for 2027. Details on XIFAXAN and safety information included

Salix Pharmaceuticals XIFAXAN Bausch Health CMS Drug Price Negotiation
BRIEF

published on 12/12/2024 at 13:05, 11 months 23 days ago

Bausch Health Considers Potential Sale of Bausch + Lomb

Bausch Health Strategic Plans Stock Volatility Sale Rumors Bausch + Lomb
PRESS RELEASE

published on 12/12/2024 at 13:00, 11 months 23 days ago

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Bausch Health considers potential sale of subsidiary Bausch + Lomb to complete full separation. Response to CIRO's request regarding market rumors and stock volatility

Bausch Health CIRO Market Rumors Stock Volatility Subidiary Sale
BRIEF

published on 12/05/2024 at 14:05, 11 months 30 days ago

Second Annual Opioid-Induced Constipation Awareness Day Recognized

Salix Pharmaceuticals Bausch Health Chronic Pain Opioid-Induced Constipation Awareness Day
PRESS RELEASE

published on 12/05/2024 at 14:00, 11 months 30 days ago

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Bausch Health Companies Inc., Salix Pharmaceuticals, and healthcare organizations join forces for the second annual Opioid-Induced Constipation Awareness Day to raise awareness and support patients affected by OIC

Bausch Health Companies Inc. Healthcare Organizations Awareness Opioid-Induced Constipation Awareness Day OIC
BRIEF

published on 12/02/2024 at 14:05, 1 year ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Innovation Pharmaceuticals R&D Bausch Health Jonathan Sadeh
PRESS RELEASE

published on 12/02/2024 at 14:00, 1 year ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D
Bausch Health Companies Inc. appoints Jonathan Sadeh M.D., M.Sc as Executive VP, Chief Medical Officer & Head of R&D, emphasizing commitment to innovation & excellence

Innovation Bausch Health Companies Inc. R&D Chief Medical Officer Jonathan Sadeh
BRIEF

published on 11/18/2024 at 14:05, 1 year ago

Bausch Health's CABTREO Receives Positive Reimbursement Endorsements in Canada

Bausch Health Dermatology Acne Treatment Canada Drug Approval Reimbursement Endorsement
PRESS RELEASE

published on 11/18/2024 at 14:00, 1 year ago

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Bausch Health, Canada announces positive reimbursement recommendations for new acne treatment CABTREO, the first triple-combination topical therapy approved in Canada

Bausch Health CABTREO Canada Acne Treatment Reimbursement

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 3 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 8 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 38 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 33 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 38 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 33 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 38 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 38 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 24 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 8 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 53 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 38 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 53 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 54 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE